Unknown

Dataset Information

0

Histological validation of fast macromolecular proton fraction mapping as a quantitative myelin imaging method in the cuprizone demyelination model.


ABSTRACT: Cuprizone-induced demyelination in mice is a frequently used model in preclinical multiple sclerosis research. A recent quantitative clinically-targeted MRI method, fast macromolecular proton fraction (MPF) mapping demonstrated a promise as a myelin biomarker in human and animal studies with a particular advantage of sensitivity to both white matter (WM) and gray matter (GM) demyelination. This study aimed to histologically validate the capability of MPF mapping to quantify myelin loss in brain tissues using the cuprizone demyelination model. Whole-brain MPF maps were obtained in vivo on an 11.7T animal MRI scanner from 7 cuprizone-treated and 7 control ?57BL/6 mice using the fast single-point synthetic-reference method. Brain sections were histologically stained with Luxol Fast Blue (LFB) for myelin quantification. Significant (p?

SUBMITTER: Khodanovich MY 

PROVIDER: S-EPMC5402392 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Histological validation of fast macromolecular proton fraction mapping as a quantitative myelin imaging method in the cuprizone demyelination model.

Khodanovich Marina Yu MY   Sorokina Irina V IV   Glazacheva Valentina Yu VY   Akulov Andrey E AE   Nemirovich-Danchenko Nikolay M NM   Romashchenko Alexander V AV   Tolstikova Tatyana G TG   Mustafina Lilia R LR   Yarnykh Vasily L VL  

Scientific reports 20170424


Cuprizone-induced demyelination in mice is a frequently used model in preclinical multiple sclerosis research. A recent quantitative clinically-targeted MRI method, fast macromolecular proton fraction (MPF) mapping demonstrated a promise as a myelin biomarker in human and animal studies with a particular advantage of sensitivity to both white matter (WM) and gray matter (GM) demyelination. This study aimed to histologically validate the capability of MPF mapping to quantify myelin loss in brain  ...[more]

Similar Datasets

| S-EPMC5987939 | biostudies-literature
| S-EPMC8271044 | biostudies-literature
| S-EPMC4403969 | biostudies-literature
| S-EPMC8711191 | biostudies-literature
| S-EPMC7478173 | biostudies-literature
| S-EPMC6160739 | biostudies-literature
| S-EPMC6508663 | biostudies-literature
| S-EPMC5183566 | biostudies-literature
| S-EPMC5303642 | biostudies-literature
| S-EPMC5710130 | biostudies-literature